The early recognition and treatment of amyloidosis in order to minimise the effects of decline in health. Our focus is therefore on the improvement of diagnosis and the treatment of patients with amyloidosis. In addition, we offer information to patients, physicians and other individuals involved.
Who we are
The Groningen Amyloidosis Center of Expertise is a collaboration of various disciplines at the University Medical Center Groningen, engaged in diagnosis and treatment of systemic and localised amyloidosis. The department of Internal Medicine has a coordinating role.
|XVIII. International Symposium on Amyloidosis||4th – 8th September 2022||For information visit the website|
|How do we deal with the corona virus at the UMCG (COVID-19)?||On this page you will find all information about how we deal with the corona virus at the UMCG (COVID-19)|
|The International Society of Amyloidosis (ISA) has given recommendations for the management of amyloidosis patients during the COVID-19 pandemic||View the latest version here (April 20, 2020)|
|World Amyloidosis day||View the presentations of the AL amyloidosis webinar on the first World Amyloidosis Day of October 26, 2021.||View the Wordwide actions here.|
|Stichting Amyloïdose Nederland (SAN)||View the presentations held on the Informationday of September 25, 2021.||View the presentations held on the patient meeting day of March 13, 2021.|
|Expertisenetwerk Amyloïdose||December 2019 on-line|